Selway Asset Management’s United Therapeutics UTHR Stock Holding History

Selway Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,025	Closed	-$238K	–	76
2019 Q1	$238K	Sell	2,025 -50	-2%	-$5.83K	0.16%	73
2018 Q4	$226K	Hold	2,075	–	–	0.17%	66
2018 Q3	$265K	Hold	2,075	–	–	0.16%	70
2018 Q2	$235K	Hold	2,075	–	–	0.14%	72
2018 Q1	$233K	Sell	2,075 -2,600	-56%	-$330K	0.14%	69
2017 Q4	$692K	Sell	4,675 -200	-4%	-$25.4K	0.41%	58
2017 Q3	$571K	Hold	4,875	–	–	0.33%	60
2017 Q2	$632K	Sell	4,875 -600	-11%	-$74.8K	0.36%	65
2017 Q1	$741K	Sell	5,475 -12,000	-69%	-$1.82M	0.42%	64
2016 Q4	$2.51M	Sell	17,475 -1,000	-5%	-$128K	1.5%	25
2016 Q3	$2.18M	Buy	18,475 +14,775	+399%	+$1.78M	1.36%	30
2016 Q2	$392K	Buy	+3,700	New	+$413K	0.25%	68
2015 Q3	–	Sell	-15,900	Closed	-$2.77M	–	69
2015 Q2	$2.77M	Hold	15,900	–	–	1.52%	31
2015 Q1	$2.74M	Sell	15,900 -24,900	-61%	-$3.8M	1.45%	32
2014 Q4	$5.28M	Sell	40,800 -4,500	-10%	-$580K	2.85%	7
2014 Q3	$5.83M	Buy	+45,300	New	+$4.67M	2.81%	7

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Selway Asset Management's UTHR Position: Q2 2019 in Review

Selway Asset Management sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 2,025 shares — an estimated $238K sold.

Selway Asset Management first reported a position in UTHR in Q3 2014 and held it in 16 quarters. The position peaked at $5.83M in Q3 2014. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

Selway Asset Management reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
Selway Asset Management sold 2,025 United Therapeutics shares in Q2 2019, an estimated $238K.
Selway Asset Management first reported a position in United Therapeutics in Q3 2014 and held it in 16 quarters.
Selway Asset Management's United Therapeutics position peaked at $5.83M in Q3 2014.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Selway Asset Management's 13F filing for Q2 2019, filed 30 Jul 2019.